Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Not Confirmed
Not Confirmed
11-13 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Industry Trade Show
Not Confirmed
11-13 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/medical-breakthroughs-in-2024-alzheimer-s-schizophrenia-copd-mash-see-pathbreaking-treatments
20 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/kangpu-completed-bridging-clinical-study-of-kpg-818-in-china-302254025.html
10 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/kangpu-biopharmaceuticals-to-present-results-from-phase-2a-of-kpg-818-in-sle-at-eular-2024-302168112.html
20 Feb 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/kangpu-biopharmaceuticals-to-present-preclinical-efficacy-data-of-kpg-818-in-crohns-disease-at-the-19th-congress-of-ecco-ind-application-for-phase-ii-in-progress-302064814.html
19 Mar 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/kangpu-completes-patient-enrollment-for-phase-iia-clinical-trial-of-kpg-818-in-sle-in-the-us-301775628.html
12 Jun 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/kangpu-announces-first-patient-dosed-in-the-us-phase-iia-clinical-trial-of-neomides-molecular-glue-kpg-818-in-systemic-lupus-erythematosus-301566187.html
17 Nov 2020
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/kangpu-biopharmaceuticals-initiates-phase-ibiia-clinical-trial-of-kpg-818-in-systemic-lupus-erythematosus-301173374.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?